Global health or global wealth?

Nature Biotechnology

Volumn 28, Issue 9, 2010, Pages 907-909

  Rezaie, Rahim ^a   Singer, Peter A ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ORPHAN DRUG;

COMMERCIAL PHENOMENA; DRUG LEGISLATION; ECONOMIC ASPECT; FUNDING; HEALTH; HEALTH CARE ACCESS; MARKET; NOTE; PRIORITY JOURNAL;

DRUG INDUSTRY; HUMANS; LEGISLATION AS TOPIC; MARKETING; MODELS, ECONOMIC; ORPHAN DRUG PRODUCTION; SOCIOECONOMIC FACTORS; WORLD HEALTH;

EID: 77956692776     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0910-907     Document Type: Note

References (14)

1. Daar, A.S. et al. Nature 450, 494-496 (2007).
2. Gustavsen, K. & Hanson, C. Health Aff. 28, 1745-1749 (2009).
3. Towse, A. & Kettler, H. Bull. World Health Organ. 83, 301-307 (2005).
4. Grabowski, H. Health Aff. 24, 697-700 (2005).
5. Ridley, D.B., Grabowski, H.G. & Moe, J.L. Health Aff. 25,313-324 (2006).
6. Dentzer, S. Health Aff. 28, w411-w416 (2009).
7. Lister, S. GlaxoSmithKline to share malaria research in hope of finding a cure. Times Online (2010).
8. Frew, S. E. et al. Nat. Biotechnol. 26, 37-53 (2008).
9. Frew, S.E. et al. Nat. Biotechnol. 25, 403-417 (2007).
10. Rezaie, R., Frew, S.E. & Sammut, S.M. Nat. Biotechnol. 26,627-644 (2008).
11. Al-Bader, S., Frew, S.E. & Essajee, I. Nat. Biotechnol. 27,427-445 (2009).
12. 2009; accessed 10 January 2010 (2009; accessed 10 January 2010).
13. Frew, S.E., Kettler, H.E. & Singer, P.A. Health Aff. 27, 1029-1041 (2008).
14. Frew, S., Liu, V. & Singer, P. Health Aff. 28, 1760-1773 (2009).